Laserfiche WebLink
from coordinated Settlement discussions detailed in this Section upon 10 <br />business days' written notice to the remaining Committee Members and <br />counsel for any affected Pharmaceutical Supply Chain Participant. The <br />withdrawal of any Member releases the remaining Committee Members <br />from the restrictions and obligations in this Section. <br />5. The obligations in this Section shall not affect any Party's right to proceed <br />with trial or, within 30 days of the date upon which a trial involving that <br />Party's claims against a specific Pharmaceutical Supply Chain Participant <br />is scheduled to begin, reach a case specific resolution with that particular <br />Pharmaceutical Supply Chain Participant. <br />F. Amendments <br />The Parties agree to make such amendments as necessary to implement the <br />intent of this agreement. <br />Acknowledgment of Agreement <br />We, the undersigned, have participated in the drafting of the above Texas <br />Term Sheet, including consideration based on comments solicited from Political <br />Subdivisions. This document has been collaboratively drafted to maintain all <br />individual claims while allowing the State and its Political Subdivisions to cooperate <br />in exploring all possible means of resolution. Nothing in this agreement binds any <br />party to any specific outcome. Any resolution under this document will require <br />12 <br />